| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.4 | 0.009 |